Practice nurse prescribers need to be registered with NHS Prescription Services reminder

Practice nurse prescribers need to be registered with NHS Prescription Services reminder

June 20 2016 Substantial numbers of nurse prescribers have not registered which practice they are...

Nurse role on CCG governing bodies highlighted in NHSCC report

Nurse role on CCG governing bodies highlighted in NHSCC report

June 1 2016 A new report has highlighted how the role of nurse members of clinical commissioning...

First month of full nurse revalidation considered a ‘major success’

First month of full nurse revalidation considered a ‘major success’

May 9 2016 Last month’s introduction of revalidation for nurses has not led to any loss of...

Vulnerable people are being turned away from GP surgeries

Vulnerable people are being turned away from GP surgeries

May 4 2016 Almost two fifths of GP practices have refused to register new patients, a charity has...

  • Practice nurse prescribers need to be registered with NHS Prescription Services reminder

    Practice nurse prescribers need to be registered with NHS Prescription Services reminder

    Tuesday, 21 June 2016 10:34
  • Nurse role on CCG governing bodies highlighted in NHSCC report

    Nurse role on CCG governing bodies highlighted in NHSCC report

    Sunday, 05 June 2016 23:25
  • First month of full nurse revalidation considered a ‘major success’

    First month of full nurse revalidation considered a ‘major success’

    Monday, 09 May 2016 14:37
  • Vulnerable people are being turned away from GP surgeries

    Vulnerable people are being turned away from GP surgeries

    Wednesday, 04 May 2016 09:04

adhdDecember 2 2015

Researchers have urged doctors to be cautious if considering prescribing methylphenidate for children or adolescents with attention deficit hyperactivity disorder (ADHD).

A Cochrane review has concluded that the drug may improve teacher-reported ADHD symptoms, teacher-reported general behaviour, and parent-reported quality of life among children and adolescents diagnosed with ADHD. “However, the low quality of the underpinning evidence means that we cannot be certain of the magnitude of the effects.”

The researchers assessed 38 parallel-group trials and 147 cross-over trials, representing over 12,200 patients, and found methylphenidate led to “modest” improvements in ADHD symptoms as a primary outcome. They also found there were improvements in general behaviour and quality of life. However, in all outcomes, the quality of the evidence was judged to be “very low”.

Data for serious adverse events was only reported in nine out of the 185 trials, meaning that while methylphenidate does not appear to be associated with an increased risk of serious adverse events, the quality of the evidence was again very low.

“It was apparent from assessing the included trials that it would have been possible for people involved in the trials to have been aware of which treatment the children were taking,” says Cochrane. “In addition, the reporting of results was not complete in many of the trials, and for some analyses there was variation among trial results.

“Based upon this information, the researchers urge clinicians to be cautious in prescribing methylphenidate, and to weigh up the benefits and risks more carefully.”

Professor Ole Jakob Storebø, a clinical psychologist from the Psychiatric Research Unit in Region Zealand, Denmark, led the team of 18 researchers carrying out the meta-analysis. “This review highlights the need for long-term, large, better-quality randomized trials so that we can determine the average effect of this drug more reliably,” he said.

Co-author Camilla Groth MD added: “This review shows very limited quality evidence for the effects of methylphenidate on children and adolescents with ADHD. Some might benefit, but we still don’t know which patients will do so. Clinicians prescribing methylphenidate must take account of the poor quality of the evidence, monitor treatment carefully, and weigh up the benefits and adverse effects.”

Links:

Cochrane announcement

Cochrane review summary

Ole Jakob Storebø et al. ‘Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)’. Cochrane Library. Published online November 25 2015.

Management News

June 29 2016 New guidance for healthcare professionals to support pregnant women experiencing nausea and vomiting and hyperemesis gravidum have been published.
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...